MedPath

上海迪赛诺化学制药有限公司

Ownership
-
Established
2002-05-16
Employees
-
Market Cap
-
Website
https://www.desano.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

齐多夫定

Approval Number
国药准字H20040437
Approval Date
Jun 9, 2020
NMPA

奈韦拉平

Approval Number
国药准字H20020579
Approval Date
Apr 21, 2020
NMPA

拉米夫定

Approval Number
国药准字H20083560
Approval Date
Jun 24, 2019
NMPA

Ritonavir

Product Name
利托那韦
Approval Number
国药准字H20173132
Approval Date
Mar 22, 2017
NMPA

Efavirenz

Product Name
依非韦伦
Approval Number
国药准字H20163454
Approval Date
Dec 23, 2016
NMPA

盐酸伐昔洛韦

Approval Number
国药准字H20063047
Approval Date
Nov 5, 2015
NMPA

司他夫定

Approval Number
国药准字H20020476
Approval Date
Jan 23, 2015
NMPA

Didanosine

Product Name
去羟肌苷
Approval Number
国药准字H20020471
Approval Date
Apr 16, 2010
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.